Stock-Based Compensation for Illumina (ILMN)
Stock-Based Compensation for Illumina (ILMN): headline value $216.00M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ILMN
Currently viewingStock-Based CompensationSwitch metric
Latest period
$216.00M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2021)
$754.00M
Latest annual
$0
Stock-Based Compensation history chart for Illumina (ILMN) from 1999 to 2025
Stock-Based Compensation history table for Illumina (ILMN) from 1999 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $0 | -100.0% | ||
| 2024 | $370.00M | -2.6% | ||
| 2023 | $380.00M | +3.8% | ||
| 2022 | $366.00M | -51.5% | ||
| 2021 | $754.00M | +288.7% | ||
| 2020 | $194.00M | 0.0% | ||
| 2019 | $194.00M | +0.5% | ||
| 2018 | $193.00M | +17.7% | ||
| 2017 | $164.00M | +27.1% | ||
| 2016 | $129.06M | -2.7% | ||
| 2015 | $132.59M | -13.1% | ||
| 2014 | $152.55M | +44.2% | ||
| 2013 | $105.83M | +12.2% | ||
| 2012 | $94.32M | +2.4% | ||
| 2011 | $92.09M | +28.5% | ||
| 2010 | $71.64M | +17.8% | ||
| 2009 | $60.81M | +27.5% | ||
| 2008 | $47.69M | +41.3% | ||
| 2007 | $33.75M | +135.9% | ||
| 2006 | $14.30M | +5197.8% | ||
| 2005 | $270,000 | -68.0% | ||
| 2004 | $844,000 | -65.6% | ||
| 2003 | $2.45M | -43.7% | ||
| 2002 | $4.36M | -25.5% | ||
| 2001 | $5.85M | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — |
Stock-Based Compensation values are taken from Illumina's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Illumina (ILMN) stock-based compensation totalled $0 – plunged 100.0% year-over-year.
Illumina stock-based compensation has contracted on net over the period, with a -100.0% compound annual growth rate over 2020–2025 (5 years).
2021 marks the peak stock-based compensation at $754.00M, with the historical low of $0 recorded in 1999.
Illumina (ILMN) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
Illumina Stock-Based Compensation by Year
Illumina Stock-Based Compensation 2025: $0
Illumina stock-based compensation in 2025 was $0, plunged 100.0% below 2024.
Illumina Stock-Based Compensation 2024: $370.00M
Illumina stock-based compensation in 2024 was $370.00M, edged down 2.6% below 2023.
Illumina Stock-Based Compensation 2023: $380.00M
Illumina stock-based compensation in 2023 was $380.00M, edged up 3.8% from 2022.
Illumina Stock-Based Compensation 2022: $366.00M
Illumina stock-based compensation in 2022 was $366.00M, plunged 51.5% below 2021.
Illumina Stock-Based Compensation 2021: $754.00M
Illumina stock-based compensation in 2021 was $754.00M.
See more financial history for Illumina (ILMN).
Sector peers — Stock-Based Compensation
Companies in the same sector as Illumina, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Illumina's stock-based compensation?
Latest reported stock-based compensation for Illumina (ILMN) is $216.00M (period ending December 28, 2025).
How has Illumina stock-based compensation changed year-over-year?
Illumina (ILMN) stock-based compensation changed -100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Illumina stock-based compensation?
Illumina (ILMN) stock-based compensation compound annual growth rate is -100.0% over the most recent 5 years available.
When did Illumina stock-based compensation hit its highest annual value?
Illumina stock-based compensation reached its highest annual value of $754.00M in 2021.
What was Illumina stock-based compensation in 2024?
Illumina (ILMN) stock-based compensation in 2024 was $370.00M.
What was Illumina stock-based compensation in 2025?
Illumina (ILMN) stock-based compensation in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ILMN Overview
Company profile, financial tools, and key metrics
ILMN Revenue Counter
Earns $137.68 every second. See per minute, hour, and day.
ILMN Earnings Counter
Earns $26.95 per second net profit. See per minute, hour, and day.
ILMN Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
ILMN What If Invested
What if you had invested $1,000? See historical returns from any date.
ILMN How It Makes Money
Discover visual breakdown of $4.34B in revenue — where it comes from and where it goes.
ILMN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ILMN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ILMN Daily Price Character
Explosive · 50.0% historical win rate (green days). Streaks & record days.
ILMN Buybacks
3.61% TTM buyback yield. Shareholder yield & SBC comparison.
ILMN Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.